Skip to main content
. 2019 May 2;13:781–787. doi: 10.2147/OPTH.S203648

Table 3.

Ocular symptomatology (presence)

Symptom Placebo/SH
(n=73)
PRO-155/SH
(n=69)
Baseline Final Baseline Final
Burning, % 56.2 15.1 36.2 11.6
Foreign body sensation, % 56.2 24.7 50.7 14.5
Photophobia, % 39.7 16.4 34.8 4.3

Notes: Baseline vs Final visit, McNemar’s test p=0.0001.

Abbreviations: SH, sodium hyaluronate; PRO-155, bromfenac.